Jan van Deursen Selected Research

p300-CBP-associated factor

1/2018	P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
3/2014	p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan van Deursen Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 04/2003
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019 - 07/2010
2	Weight Gain 05/2021 - 10/2017
2	Inflammation (Inflammations) 05/2021 - 10/2017
2	Carcinogenesis 01/2019 - 03/2014
2	Insulin Resistance 01/2019 - 10/2017
2	Infections 02/2014 - 02/2007
2	Chromosomal Instability (Chromosome Stability) 01/2011 - 04/2005
1	Long Term Adverse Effects 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Premature Aging 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Atherosclerosis 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Melanoma (Melanoma, Malignant) 11/2017
1	Overnutrition 10/2017
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2017
1	Cysts 01/2016
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2016
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2015
1	Pain (Aches) 09/2015
1	Cardiomegaly (Heart Hypertrophy) 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 03/2014
1	Aneuploidy (Aneuploid) 12/2012
1	Glucose Intolerance 03/2012
1	Type 2 Diabetes Mellitus (MODY) 03/2012
1	T-Cell Leukemia (Leukemia, T Cell) 01/2011
1	Thrombosis (Thrombus) 09/2010
1	Disease Progression 07/2010
1	Starvation 02/2010
1	Fatty Liver 02/2010
1	Human Influenza (Influenza) 02/2007
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2006
1	Vesicular Stomatitis 01/2005
1	Virus Diseases (Viral Diseases) 01/2005
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2005
3	Serine (L-Serine)FDA Link 05/2021 - 10/2017
3	Carrier Proteins (Binding Protein)IBA 01/2018 - 04/2003
2	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2018 - 03/2014
2	p300-CBP-associated factorIBA 01/2018 - 03/2014
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018 - 11/2017
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 09/2015
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 01/2016
2	EnzymesIBA 01/2017 - 01/2011
2	CalciumIBA 01/2017 - 01/2016
2	Peptides (Polypeptides)IBA 09/2015 - 03/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	LipidsIBA 01/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2019
1	Apolipoprotein E3IBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Conditioned Culture MediaIBA 01/2018
1	OsteopontinIBA 11/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2017
1	adenylyl cyclase 6IBA 01/2017
1	diethylstilbestrol monophosphate (PDES)IBA 01/2016
1	NeuropeptidesIBA 09/2015
1	Opioid Peptides (Opioid Peptide)IBA 09/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2015
1	Dynorphins (Dynorphin)IBA 09/2015
1	preproenkephalinIBA 09/2015
1	Opioid Analgesics (Opioids)IBA 09/2015
1	Opioid Receptors (Opioid Receptor)IBA 09/2015
1	Androgen Receptors (Androgen Receptor)IBA 03/2014
1	Cyclophilins (Cyclophilin)IBA 02/2014
1	Deubiquitinating EnzymesIBA 12/2012
1	UbiquitinIBA 12/2012
1	Anaphase-Promoting Complex-CyclosomeIBA 12/2012
1	Amyloid (Amyloid Fibrils)IBA 03/2012
1	Ubiquitin-Specific ProteasesIBA 01/2011
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 09/2010
1	ferric chlorideIBA 09/2010
1	IronIBA 07/2010
1	ClathrinIBA 07/2010
1	Sirtuin 1IBA 02/2010
1	Signaling Lymphocytic Activation Molecule Associated ProteinIBA 01/2006
1	anthraceneIBA 04/2005
1	Aurora KinasesIBA 04/2005
1	Matrix-MIBA 01/2005
1	Messenger RNA (mRNA)IBA 01/2005
1	Phosphotransferases (Kinase)IBA 04/2003
1	DNA (Deoxyribonucleic Acid)IBA 04/2003

Therapy/Procedure

6	Therapeutics 01/2021 - 02/2007
1	Drug Therapy (Chemotherapy) 01/2019
1	Intraperitoneal Injections 01/2018
1	Subcutaneous Injections 01/2018
1	Aftercare (After-Treatment) 04/2005